Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Leckrone said.

Leckrone said.

posted on Sep 13, 2007 08:36AM
Commenting on the proposed partial judgment relative to US ‘584, Leckrone said, “We continue to believe that the claim construction for ‘instruction groups’ deserves more scrutiny than the Court could give it during the Markman hearing due to time and space constraints. While the proposed partial judgment we are seeking agrees to a judgment of non-infringement on this claim construction for the Texas Court trial, it will allow us to seek reversal of this interpretation in the US Court of Appeals for the Federal Circuit immediately. Otherwise, TPL would have had to wait for the end of the Texas Court trial in order to have the interpretation reviewed by the Court of Appeals.”
Share
New Message
Please login to post a reply